Clinical Trial Update: HepaStem Long-Term Safety Registry

View source ↗

Summary

This clinical trial update announces the termination of the HepaStem long-term safety registry and highlights conditions studied (urea cycle disorder, Crigler-N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crigler-najjar Syndrome
• On Chronic Liver Failure
• Urea Cycle Disorder

Drugs mentioned

• HepaStem

Snippet

Sponsor: Cellaion SA | Conditions: Urea Cycle Disorder, Crigler-Najjar Syndrome | Status: TERMINATED